Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| HCC1143 | BMS-265246 | 3.16227766017 | -0.0717 | 0.10021 |
| HCC1143 | LY3023414 | 3.16227766017 | 0.2988 | 0.06605 |
| HCC1143 | AZD5363 | 3.16227766017 | 0.8442 | 0.00664 |
| HCC1143 | BMS-265246 | 3.16227766017 | -0.0605 | 0.11645 |
| HCC1143 | Ribociclib | 3.16227766017 | 0.6333 | -0.00033 |
| HCC1143 | LY3023414 | 3.16227766017 | 0.3263 | 0.02659 |
| HCC1143 | MK 1775 | 3.16227766017 | 0.2949 | 0.09606 |
| HCC1143 | AZD2014 | 3.16227766017 | 0.3445 | 0.02151 |
| HCC1143 | AZD6738 | 3.16227766017 | 0.7282 | 0.01946 |
| HCC1143 | BMS-265246 | 3.16227766017 | -0.0230 | 0.11285 |
| HCC1143 | GSK2334470 | 3.16227766017 | 0.8957 | -0.00031 |
| HCC1143 | GSK2334470 | 3.16227766017 | 0.8125 | 0.01389 |
| HCC1143 | Ribociclib | 3.16227766017 | 0.5129 | 0.01217 |
| HCC1143 | Ribociclib | 3.16227766017 | 0.5572 | 0.00588 |
| HCC1143 | MK 1775 | 3.16227766017 | 0.3301 | 0.06612 |
| HCC1143 | MK 1775 | 3.16227766017 | 0.1603 | 0.09225 |
| HCC1143 | AZD2014 | 3.16227766017 | 0.3075 | 0.06146 |
| HCC1143 | AZD2014 | 3.16227766017 | 0.3058 | 0.02767 |
| HCC1143 | AZD5363 | 3.16227766017 | 0.8526 | 0.00377 |
| HCC1143 | AZD5363 | 3.16227766017 | 0.8429 | 0.00015 |
| HCC1143 | AZD6738 | 3.16227766017 | 0.7735 | 0.03587 |
| HCC1143 | AZD6738 | 3.16227766017 | 0.7967 | 0.02386 |
| HCC1143 | GSK2334470 | 3.16227766017 | 0.9047 | -0.00270 |
| HCC1143 | RO-3306 | 3.16227766017 | 0.3550 | 0.05759 |
| HCC1143 | LY3023414 | 3.16227766017 | 0.3593 | 0.01138 |